Thomas E. Needham Jr. SEC EDGAR Filings (CIK 0001712568)

SEC EDGAR filings, ownership reports, and insider transactions for Thomas E. Needham Jr..

Business address
Merrimack Pharmaceuticals, Inc., One Kendall Square, Suite B7201, Cambridge, MA, 02139
Get insider transactions for this reporting owner
Thomas E. Needham Jr. has filed 6 SEC EDGAR filings since 25 Jul 2017

Latest Filings

Recent SEC filings for Thomas E. Needham Jr. including 4, 3.

Form type Document Filing Description Filing date Reporting date File number(s)
4 Open 4 document View SEC filing for 4 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES 05 Dec 2022 01 Dec 2022 001-39271
4 Open 4 document View SEC filing for 4 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES 27 May 2022 25 May 2022 001-39271
4 Open 4 document View SEC filing for 4 PRIMARY DOCUMENT 08 Sep 2021 03 Sep 2021 001-39271
3 Open 3 document View SEC filing for 3 PRIMARY DOCUMENT 08 Sep 2021 02 Sep 2021 001-39271
4 Open 4 document View SEC filing for 4 FORM 4 SUBMISSION 03 Aug 2017 01 Aug 2017 001-35409
3 Open 3 document View SEC filing for 3 FORM 3 SUBMISSION 25 Jul 2017 24 Jul 2017 001-35409

About this filer

Thomas E. Needham Jr. files with the SEC under CIK 0001712568. This page aggregates EDGAR filings and related ownership activity.

See reporting owner transactions.

FAQ

What is a CIK?
A Central Index Key (CIK) is a unique identifier assigned by the SEC to each filer.
Why are some filings missing?
New filings appear as the SEC updates EDGAR, and older records can vary by availability.
How often is this page updated?
Updates follow new EDGAR submissions and periodic data refreshes.

Related pages